March 2014 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Where a product does not have a current Pharmacode, suppliers are required to ensure a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2012/13 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2016
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type | Current subsidy and price (brand) | New subsidy and price | Sole supply brand (Supplier) |
Date of listing/subsidy change for tender winning brand | Date of reference pricing of other listed brands | Sole Subsidised Supply date (and delisting of other listed brands) | Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Pramipexole hydrochloride | Tab 0.25 mg; 100 tablets, blister pack |
$7.20 per 100 tablets (Ramipex) $2.40 per 30 tablets (Dr Reddy’s) |
$7.20 per 100 tablets | Ramipex (Deva Holdings) |
1 August 2014 | 1 October 2014 | 1 January 2015 | Dr Reddy's Pramipexole (Dr Reddy's) |
| Pramipexole hydrochloride | Tab 1 mg; 100 tablets, blister pack |
$24.39 per 100 tablets (Ramipex) $7.20 per 30 tablets (Dr Reddy’s) |
$24.39 per 100 tablets | Ramipex (Deva Holdings) |
1 August 2014 | Not applicable | 1 January 2015 | Dr Reddy's Pramipexole (Dr Reddy's) |
| *Dr Reddy’s brand of pramipexole hydrochloride 0.125 mg and 0.5 mg tablet will also be delisted from Section B of the Pharmaceutical Schedule from 1 January 2015. | ||||||||
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) | Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
| Loperamide hydrochloride | Cap 2 mg; 400 capsules, blister pack |
$8.95 | $7.84 | Diamide Relief (Mylan) |
1 May 2014 | 1 August 2014 |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current pack price (brand) |
New pack price |
Hospital Supply Brand (Supplier) |
DV Limit |
Date of listing/price change for tender winning brand | Hospital Supply Status date (and delisting of other listed brands) | Brand (Supplier) to be delisted |
|---|---|---|---|---|---|---|---|---|
| Pramipexole hydrochloride | Tab 0.25 mg; 100 tablets, blister pack |
$7.20 per 100 tablets (Ramipex) $2.40 per 30 tablets (Dr Reddy’s) |
$7.20 per 100 tablets | Ramipex (Deva Holdings) |
1 % | 1 August 2014 | 1 October 2014 | Dr Reddy's Pramipexole (Dr Reddy's) |
| Pramipexole hydrochloride | Tab 1 mg; 100 tablets, blister pack |
$24.39 per 100 tablets (Ramipex) $7.20 per 30 tablets (Dr Reddy’s) |
$24.39 per 100 tablets | Ramipex (Deva Holdings) |
1 % | 1 August 2014 | 1 October 2014 | Dr Reddy's Pramipexole (Dr Reddy's) |
| *Dr Reddy’s brand of pramipexole hydrochloride 0.125 mg and 0.5 mg tablet will also be delisted from Part II of Section H of the Pharmaceutical Schedule from 1 October 2014. | ||||||||
Tenders awarded to listed pharmaceuticals where only the current brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current pack price | New pack price | Hospital Supply Brand (Supplier) |
DV Limit |
Date of price change | Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
| Loperamide hydrochloride | Cap 2 mg; 400 capsules, blister pack |
$8.95 | $7.84 | Diamide Relief (Mylan) |
1% | 1 May 2014 | 1 July 2014 |
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type | Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) | Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
| Acetazolamide | Tab 250 mg; 100 tablets, bottle |
$17.03 | $17.03 | Diamox (Aspen) |
1 July 2014 | 1 October 2014 |
| Atropine sulphate | Eye drops 1%; 15 ml, dropper bottle |
$17.36 | $17.36 | Atropt (Aspen) |
1 May 2014 | 1 August 2014 |
| Betaxolol | Eye drops 0.25%; 5 ml OP, dropper bottle |
$11.80 | $11.80 | Betoptic S (Alcon) |
1 July 2014 | 1 October 2014 |
| Betaxolol | Eye drops 0.5%; 5 ml OP, dropper bottle |
$7.50 | $7.50 | Betoptic (Alcon) |
1 July 2014 | 1 October 2014 |
| Cyclopentolate hydrochloride | Eye drops 1%; 15 ml OP, dropper bottle |
$8.76 | $8.76 | Cyclogyl (Alcon) |
1 July 2014 | 1 October 2014 |
| Dapsone | Tab 100 mg; 100 tablets |
$110.00 | $110.00 | Dapsone (Link) |
1 July 2014 | 1 October 2014 |
| Dapsone | Tab 25 mg; 100 tablets |
$95.00 | $95.00 | Dapsone (Link) |
1 July 2014 | 1 October 2014 |
| Dexamethasone with neomycin sulphate and polymyxin B sulphate | Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml ; 5 ml OP, dropper bottle |
$4.50 | $4.50 | Maxitrol (Alcon) |
1 July 2014 | 1 October 2014 |
| Dexamethasone with neomycin sulphate and polymyxin B sulphate | Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per g; 3.5 g OP tube |
$5.39 | $5.39 | Maxitrol (Alcon) |
1 July 2014 | 1 October 2014 |
| Diclofenac sodium | Eye drops 0.1%; 5 ml OP, dropper bottle |
$13.80 | $13.80 | Voltaren Ophtha Eye Drop 5mL (Alcon) |
1 July 2014 | 1 October 2014 |
| Isosorbide mononitrate | Tab 20 mg; 100 tablets blister pack |
$17.10 | $17.10 | Ismo 20 (Riemser) |
1 July 2014 | 1 October 2014 |
| Lithium carbonate | Cap 250 mg; 100 capsules bottle pack |
$9.42 | $9.42 | Douglas (Douglas) |
1 July 2014 | 1 October 2014 |
| Lodoxamide | Eye drops 0.1%; 10 ml OP, dropper bottle |
$8.71 | $8.71 | Lomide (Alcon) |
1 July 2014 | 1 October 2014 |
| Mebeverine hydrochloride | Tab 135 mg ; 90 tablets blister pack |
$18.00 | $18.00 | Colofac (Abbott) |
1 July 2014 | 1 October 2014 |
| Naphazoline hydrochloride | Eye drops 0.1%; 15 ml OP, dropper bottle |
$4.15 | $4.15 | Naphcon Forte (Alcon) |
1 July 2014 | 1 October 2014 |
| Paraffin liquid with wool fat | Eye oint 3% with wool fat 3%; 3.5 g OP, tube |
$3.63 | $3.63 | Poly-Visc (Alcon) |
1 May 2014 | 1 August 2014 |
| Pilocarpine hydrochloride | Eye drops 1%; 15 ml OP, dropper bottle |
$4.26 | $4.26 | Isopto (Alcon) |
1 July 2014 | 1 October 2014 |
| Pilocarpine hydrochloride | Eye drops 2%; 15 ml OP, dropper bottle |
$5.35 | $5.35 | Isopto (Alcon) |
1 July 2014 | 1 October 2014 |
| Pilocarpine hydrochloride | Eye drops 4%; 15 ml OP, dropper bottle |
$7.99 | $7.99 | Isopto (Alcon) |
1 July 2014 | 1 October 2014 |
| Poloxamer | Oral drops 10%; 30 ml OP, bottle |
$3.78 | $3.78 | Coloxyl (Aspen) |
1 July 2014 | 1 October 2014 |
| Procaine penicillin | Inj 1.5 g in 3.4 ml syringe; 5 syringes |
$123.50 | $123.50 | Cilicaine (Aspen) |
1 July 2014 | 1 October 2014 |
| Temazepam | Tab 10 mg ; 25 tablets, blister pack |
$1.27 | $1.27 | Normison (Aspen) |
1 July 2014 | 1 October 2014 |
| Testosterone cypionate | Inj 100 mg per ml, 10 ml vial; 1 vial |
$76.50 | $76.50 | Depo-Testosterone (Pfizer) | 1 July 2014 | 1 October 2014 |
| Tobramycin | Eye drops 0.3%; 5 ml OP, dropper bottle |
$11.48 | $11.48 | Tobrex (Alcon) |
1 July 2014 | 1 October 2014 |
| Tobramycin | Eye oint 0.3%; 3.5 g OP, tube |
$10.45 | $10.45 | Tobrex (Alcon) |
1 July 2014 | 1 October 2014 |
| Verapamil hydrochloride | Tab 80 mg; 100 tablets, blister pack |
$11.74 | $11.74 | Isoptin (Abbott) |
1 July 2014 | 1 October 2014 |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where no brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type | Pack price | Hospital Supply Brand (Supplier) | DV Limit | Listing date | Hospital Supply Status date |
|---|---|---|---|---|---|---|
| Betaxolol | Eye drops 0.25%; 5 ml , dropper bottle |
$11.80 | Betoptic S (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Betaxolol | Eye drops 0.5%; 5 ml , dropper bottle |
$7.50 | Betoptic (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Cyclopentolate hydrochloride | Eye drops 1%; 15 ml , dropper bottle |
$8.76 | Cyclogyl (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Lodoxamide | Eye drops 0.1%; 10 ml , dropper bottle |
$8.71 | Lomide (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Pilocarpine hydrochloride | Eye drops 1%; 15 ml , dropper bottle |
$4.26 | Isopto (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Pilocarpine hydrochloride | Eye drops 2%; 15 ml , dropper bottle |
$5.35 | Isopto (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Pilocarpine hydrochloride | Eye drops 4%; 15 ml , dropper bottle |
$7.99 | Isopto (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
Tenders awarded to listed pharmaceuticals where only the current brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type | Current pack price | New pack price | Hospital Supply Brand (Supplier) | DV Limit | Date of price change | Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
| Acetazolamide | Tab 250 mg; 100 tablets, bottle |
$17.03 | $17.03 | Diamox (Aspen) |
1% | 1 July 2014 | 1 September 2014 |
| Atropine sulphate | Eye drops 1%; 15 ml, dropper bottle |
$17.36 | $17.36 | Atropt (Aspen) |
1% | 1 May 2014 | 1 July 2014 |
| Bupivacaine hydrochloride | Inj 2.5 mg per ml, 100 ml bag; 5 bags | $150.00 | $150.00 | Marcain (AstraZeneca) | 1% | 1 May 2014 | 1 July 2014 |
| Bupivacaine hydrochloride | Inj 5 mg per ml, 4 ml ampoule; 5 ampoules | $50.00 | $50.00 | Marcain Isobaric (AstraZeneca) | 1% | 1 May 2014 | 1 July 2014 |
| Bupivacaine hydrochloride with adrenaline | Inj 2.5 mg per ml with adrenaline 1:400,000, 20 ml vial ; Single dose Top Hat SDV 20 ml vials, 5 dose units |
$135.00 | $135.00 | Marcain with Adrenaline (AstraZeneca) |
1% | 1 July 2014 | 1 September 2014 |
| Bupivacaine hydrochloride with adrenaline - | Inj 5 mg per ml with adrenaline 1:200,000, 20 ml vial; single dose top hat 20 ml vial, 5 dose units |
$115.00 | $115.00 | Marcain with Adrenaline (AstraZeneca) |
1% | 1 July 2014 | 1 September 2014 |
| Dapsone | Tab 100 mg; 100 tablets | $110.00 | $110.00 | Dapsone (Link) |
1% | 1 July 2014 | 1 September 2014 |
| Dapsone | Tab 25 mg ; 100 tablets | $95.00 | $95.00 | Dapsone (Link) |
1% | 1 July 2014 | 1 September 2014 |
| Dexamethasone with neomycin sulphate and polymyxin B sulphate | Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml ; 5 ml , dropper bottle |
$4.50 | $4.50 | Maxitrol (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Dexamethasone with neomycin sulphate and polymyxin B sulphate | Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per g; 3.5 g , tube | $5.39 | $5.39 | Maxitrol (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Diclofenac sodium | Eye drops 0.1%; 5 ml , dropper bottle |
$13.80 | $13.80 | Voltaren Ophtha Eye Drop 5mL (Alcon) | 1% | 1 July 2014 | 1 September 2014 |
| Isosorbide mononitrate | Tab 20 mg; 100 tablets blister pack |
$17.10 | $17.10 | Ismo-20 (Riemser) |
1% | 1 July 2014 | 1 September 2014 |
| Lithium carbonate | Cap 250 mg; 100 capsules bottle pack |
$9.42 | $9.42 | Douglas (Douglas) |
1% | 1 July 2014 | 1 September 2014 |
|
|
|
||||||
| Mebeverine hydrochloride | Tab 135 mg ; 90 tablets blister pack |
$18.00 | $18.00 | Colofac (Abbott) |
1% | 1 July 2014 | 1 September 2014 |
| Naphazoline hydrochloride | Eye drops 0.1%; 15 ml dropper bottle |
$4.15 | $4.15 | Naphcon Forte (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Paraffin liquid with wool fat | Eye oint 3% with wool fat 3% 3.5 g , tube | $3.63 | $3.63 | Poly-Visc (Alcon) |
1% | 1 May 2014 | 1 July 2014 |
| Poloxamer | Oral drops 10%; 30 ml , bottle |
$3.78 | $3.78 | Coloxyl (Aspen) |
1% | 1 July 2014 | 1 September 2014 |
| Procaine penicillin | Inj 1.5 g in 3.4 ml syringe; 5 syringes |
$123.50 | $123.50 | Cilicaine (Aspen) |
1% | 1 July 2014 | 1 September 2014 |
| Temazepam | Tab 10 mg ; 25 tablets, blister pack |
$1.27 | $1.27 | Normison (Aspen) |
1% | 1 July 2014 | 1 September 2014 |
| Testosterone cypionate | Inj 100 mg per ml, 10 ml vial; 1 vial | $76.50 | $76.50 | Depo-Testosterone (Pfizer) | 1% | 1 July 2014 | 1 September 2014 |
| Tobramycin | Eye drops 0.3%; 5 ml , dropper bottle |
$11.48 | $11.48 | Tobrex (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Tobramycin | Eye oint 0.3%; 3.5 g , tube |
$10.45 | $10.45 | Tobrex (Alcon) |
1% | 1 July 2014 | 1 September 2014 |
| Verapamil hydrochloride | Tab 80 mg; 100 tablets, blister pack |
$11.74 | $11.74 | Isoptin (Abbott) |
1% | 1 July 2014 | 1 September 2014 |
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2012/13 Invitation to Tender, dated 31 October 2012 and the 2013/14 Invitation to Tender, dated 07 November 2013:
2012/13 Invitation to tender
| Chemical Name | Line Item |
|---|---|
| Pramipexole hydrochloride | Tab 0.5 mg |
2013/14 Invitation to Tender
| Chemical Name | Line Item | Chemical Name | Line Item |
|---|---|---|---|
| Acetazolamide | Inj 500mg | Cyclopentolate hydrochloride | Eye drops 1%, single dose |
| Aprepitant | Cap 125 mg | Doxycycline hydrochloride | Tab 50 mg |
| Aprepitant | Cap 40 mg | Metoclopramide hydrochloride | Oral liq 5 mg per 5 ml |
| Aprepitant | Cap 80 mg | Pilocarpine hydrochloride | Eye drops 2% single dose |
| Atropine sulphate | Eye drops 1%, single dose | Timolol maleate | Tab 10 mg |
| Cyclopentolate hydrochloride | Eye drops 0.5%, single dose | Verapamil hydrochloride | Tab 40 mg |
For products included in the 2011/12 Invitation to Tender, 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.